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AbsTrACT
Purpose To assess the effectiveness of surgery on all 
tendinopathies by comparing it to no treatment, sham 
surgery and exercise-based therapies for both mid-term 
(12 months) and long-term (> 12 months) outcomes.
Methods Our literature search included EMBASE, 
Medline, CINAHL and Scopus. A combined assessment 
of internal validity, external validity and precision of each 
eligible study yielded its overall study quality. Results were 
considered significant if they were based on strong (Level 
1) or moderate (Level 2) evidence.
results 12 studies were eligible. Participants had the 
following types of tendinopathy: shoulder in seven studies, 
lateral elbow in three, patellar in one and Achilles in one. 
Two studies were of good, four of moderate and six of 
poor overall quality. Surgery was superior to no treatment 
or placebo, for the outcomes of pain, function, range of 
movement (ROM) and treatment success in the short and 
midterm. Surgery had similar effects to sham surgery 
on pain, function and range of motion in the midterm. 
Physiotherapy was as effective as surgery both in the 
midterm and long term for pain, function, ROM and tendon 
force, and pain, treatment success and quality of life, 
respectively.
Conclusion We recommend that healthcare 
professionals who treat tendinopathy encourage patients 
to comply with loading exercise treatment for at least 
12 months before the option of surgery is seriously 
entertained.
InTroduCTIon
Tendinopathy poses a substantial socioeco-
nomic burden globally comprising 30% of 
all general practice musculoskeletal consul-
tations.1 Its aetiology is multifactorial and its 
exact pathophysiology remains uncertain; 
however, it appears to result from an imbal-
ance between the protective/regenerative 
changes and the pathological responses that 
result from tendon overuse.2 3 The the most 
common exacerbating factor is thought to be 
overuse (particularly during sporting activ-
ities) causing repetitive microtrauma and 
consequent degeneration due to failure of 
the healing process.4 The net result is tendon 
degeneration, weakness, tearing, and pain.5
As the research on the management of 
tendinopathy is constantly increasing, new 
treatment modalities continuously emerge 
making decisions difficult for the treating 
healthcare professionals.6 In the absence 
of complete tendon tears, loading remains 
the mainstay of treatment and it is recom-
mended as first line for all tendinopathies 
for 6 months.7 8 The choice of second-line 
treatment, which ranges from non-invasive 
modalities such as extracorporeal shock wave 
therapy (ESWT), glyceryl trinitrate patches9 
and injection therapies to invasive surgery 
remains controversial.10 11
Surgery, which may be open or 
arthroscopic, is usually reserved for patients 
whose symptoms persist despite conservative 
management and complete tendon tears; 
however, its effectiveness has been repeat-
edly questioned.6 12 While expert opinion,13 14 
guidelines15 16 and systematic reviews17 18 have 
What is already known?
 ► Much debate surrounds the role of surgical inter-
vention in chronic tendon disease. Sham surgery 
trials are the gold standard against which to judge 
the effect of surgery on clinical conditions (such as 
tendinopathy).
What are the new findings?
 ► In 12 eligible randomised controlled trials in patients 
with various tendinopathies, surgery was not supe-
rior to sham surgery in patients with tendinopathy in 
the midterm and long term.
 ► Tendon loading exercises are as effective as surgery 
both in the midterm and long term for patients’ pain, 
function and quality of life.
 ► Surgery should be reserved for selected cases and 
only after a sufficiently long course (12 months) of 
evidence-based loading exercise has failed.
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Figure 1 PRISMA flow diagram of included studies. 
PRISMA, Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses.
attempted to provide guidance to the practising clini-
cian on when surgery may be an appropriate next step 
the actual evidence from studies comparing surgical 
and non-surgical treatments on tendinopathies remains 
limited, and therefore definitive conclusions about the 
benefits and ideal timing of surgical intervention are yet 
to be reached.
Studies assessing the effectiveness of surgery in ortho-
paedics have had bias due to the inability for blinding.19 20 
In recent years, studies have compared some orthopaedic 
operations (including surgery for tendinopathy) with 
sham surgery21–23 in a double-blinded manner to mirror 
the placebo effect of surgery. In those studies, there 
were no differences between control and intervention 
groups.21–23
The aim of this systematic review was to consider 
evidence that derives from studies assessing the effec-
tiveness of surgery for tendinopathy in the general 
population. This includes comparisons of surgery (open 
or arthroscopic) with either non-surgical treatment 
modalities, sham surgery or no treatment in all tendinop-
athies with respect to the following outcome measures: 
pain, function, range of movement (ROM), force/
strength, patient satisfaction, treatment success, quality 
of life (QoL) and complications.
MeThods
The present systematic review has been conducted and 
authored according to the ‘Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses’24 (PRISMA) 
guidelines (figure 1).
eligibility
Included studies had a randomised design and compared 
surgery to any mode of non-surgical management for 
any type of tendinopathy in terms of at least one of the 
following outcomes: ‘pain’, ‘function’, ‘ROM’, ‘force/
strength’, ‘patient satisfaction’, ‘treatment success’, 
‘QoL’, ‘complications’. Non-randomised observational 
studies, case reports, case series and literature reviews 
were excluded. Participants had to be over 18 years of age 
with a clinical diagnosis of tendinopathy with or without 
radiological signs. Studies including patients with full 
tendon tears were excluded. Duration of symptoms/
signs was not a criterion, neither was length of conser-
vative treatment and follow-up. Language criterion was 
not applied.
search strategy
A thorough literature search was conducted by two of 
the authors (DC and CC) independently via Medline, 
EMBASE, Scopus and CINAHL in March 2018, with 
the following Boolean operators: ‘(tendinopathy OR 
tendinosis OR tendinitis OR tendonitis OR tennis elbow 
OR jumper’s knee OR lateral elbow tendinopathy OR 
lateral epicondylitis OR rotator cuff disease OR shoulder 
impingement OR patellar OR Achilles) AND (surgery 
OR surgical management OR surgical treatment OR 
tenotomy OR open surgery OR arthroscopic surgery) 
AND (conservative management OR conservative treat-
ment OR physiotherapy OR eccentric exercises OR 
eccentric strengthening OR stretching OR shock-wave 
therapy OR ESWT OR extracorporeal shock wave therapy 
OR ultrasound OR iontophoresis OR laser OR LLLT OR 
polidocanol OR sclerotherapy OR botox OR botulinum 
toxin OR GTN OR glyceryl trinitrate OR nitroglycerin 
OR corticosteroid injections OR platelet rich plasma OR 
PRP OR autologous blood OR sham surgery)’.
Medical Subject Heading terms were not used to mini-
mise the risk of missing relevant articles. Review articles 
were used to identify eligible articles that were missed at 
the initial search. Additionally, reference list screening 
and citation tracking in Google Scholar were performed 
for each relevant article.
screening
From a total of 874 articles that were initially identified, 
after exclusion of duplicate and non-eligible articles, title 
and abstract screening and addition of missed studies 
identified by review articles, reference list screening and 
citation tracking, 12 studies were found to fulfil the eligi-
bility criteria. Figure 1 illustrates the article screening 
process according to PRISMA guidelines.24
Quality assessment
For a thorough assessment of the studies, internal validity 
(freedom from bias), external validity (generalisability/
applicability) and precision (reproducibility/freedom 
from random error) were all assessed separately by two 
of the authors (DC and CC) independently and a third 
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independent opinion (PK) was sought where disagree-
ments existed. Quality scales and resulting scores were 
not used as these usually combine aspects of study meth-
odology with aspects of reporting; therefore, they are 
thought to be inappropriate for assessment of study 
quality.25 In addition, score cut-offs classifying studies of 
good or poor quality are usually not provided and conse-
quently these are usually made up by the author of the 
review article which can be highly variable.
For internal validity, the ‘Cochrane Collaboration’s 
tool for assessing risk of bias in randomised trials’ was 
used, which includes six questions/criteria assessing the 
risk of five specific and one non-specific (‘other’) types of 
bias.25 As ‘other’ bias, our preset assessment criteria were 
as follows: (a) adequate and appropriate inclusion and 
exclusion criteria, (b) differences between treatment and 
control groups at baseline (confounding) and (c) appro-
priateness of statistical tests deployed. External validity 
was assessed based on the population, age range and clin-
ical relevance of interventions and outcome measures. 
For the assessment of precision, the sample size, perfor-
mance of statistical power calculation and p values that 
were used to define statistical significance were taken 
into account.
In the Cochrane Collaboration’s tool, each item is clas-
sified as ‘high’, ‘low’ or ‘unclear’ risk of bias. No total 
scores are given. External validity and precision of each 
study were rated separately as of ‘high’, ‘low’ or ‘unclear’ 
risk.
Overall, studies were characterised as of ‘good’, 
‘moderate’ or ‘poor’ quality based on a combined 
assessment of their internal validity, external validity 
and precision which was again conducted by two of the 
authors independently (DC and CC) and the opinion of 
a third author was provided where the two judgements 
differed. The criteria used for overall quality assessment 
were as follows: ‘Good’-quality studies had ‘high’ risk 
of bias in <2 of the internal validity categories, external 
validity and precision; ‘Moderate’-quality studies had 
‘high’ risk bias in two of the internal validity categories, 
external validity and precision; ‘Poor’-quality studies had 
‘high’ risk of bias in >2 of the internal validity categories, 
external validity and precision.
data extraction: handling
Each of the eligible articles was initially read by the first 
author to gain familiarity and subsequently each article 
was re-read and their key characteristics were extracted 
and inserted in tables in Microsoft Word to facilitate anal-
ysis and presentation.
For the presentation of results, outcomes were 
divided into midterm (up to 1-year follow-up) and long 
term (more than 1-year follow-up). Where results were 
reported at more than one time points in the midterm 
and in the long term, the longest-term results were used 
for each study in the results tables; however, findings at 
all follow-up stages are described in text in the results 
section. Where studies used tools and questionnaires as 
part of outcome measures, their results were tabulated 
under the generic outcome category according to the 
aim of the questionnaire. Where results of their specific 
subcomponents were presented too, additional results 
were tabulated under the corresponding outcome cate-
gory: for example, where the Oxford Shoulder Score was 
used, the aim of which is functional assessment, results 
of the overall score were used for ‘function’; if the find-
ings of specific questions of the questionnaires that are 
related to ‘pain’ were also described, this specific result 
was also used for ‘pain’, etc. The outcome category 
‘complications’ included all generic and surgery-specific 
intraoperative and postoperative complications as well 
as progression of disease to full tendon tears and other 
debilitating conditions (eg, adhesive capsulitis).
To classify the strength of evidence for each outcome 
reported, we used the rating system formulated by Van 
Tulder et al,26 which consists of four levels of evidence: 
strong evidence (Level 1) is provided by generally 
consistent findings in multiple high-quality randomised 
controlled trials (RCTs). Moderate evidence (Level 2) 
is provided by generally consistent findings in one high-
quality RCT and one or more low-quality RCTs, or by 
generally consistent findings in multiple low-quality RCTs. 
Limited or conflicting evidence (Level 3) is provided by 
only 1 RCT (either high or low quality), or by inconsis-
tent findings in multiple RCTs. No evidence (Level 4) is 
defined by the absence of RCTs.
As our overall quality assessment included a ‘moder-
ate’-quality category, we extended Level 2 to ‘evidence 
provided by generally consistent findings in high-quality 
RCT and one or more low-quality or moderate-quality 
RCTs or multiple-moderate-quality RCTs’. Two of the 
authors (DC and CC) jointly decided on the level of 
evidence for each outcome based on the aforementioned 
system without any disagreements. Results were consid-
ered to be significant when they were based on either 
strong or moderate evidence.
definitions and acronyms
Physiotherapy (any tendon rehabilitation regime admin-
istered regularly aiming to strengthen the affected tendon 
includes ‘supervised exercises’ and ‘eccentric training’; 
does NOT include standard postoperative rehabilita-
tion); sham surgery (a faked surgical intervention that 
omits the step thought to be therapeutically necessary); 
ORI-TETS (the Orthopaedic Research Institute Tennis 
Elbow Testing System); OSS (Oxford Shoulder Score); 
SDQ (Strengths and Difficulties Questionnaire); HADS 
(Hospital Anxiety and Depression Score); VAS (Visual 
Analogue Scale); EQ VAS (EuroQoL VAS); EQ-5D-3L 
(EuroQoL 5 Dimensions 3 Level index); PRIM (Project 
on Research and Intervention in Monotonous work); 
QoL (Quality of Life); UCLA (University of California 
Los Angeles score); VISA (Victorian Institute of Sport 
Assessment); ROM: range of movement; 15D (15-dimen-
sional).
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resulTs
A total of 12 eligible studies were identified with a total 
of n=1051 participants (mean 87.4±80.9) with n=1056 
affected tendons (five bilateral); of these, n=459 tendons 
had surgery, n=258 tendons received non-surgical treat-
ments (n=178 physiotherapy, n=50 ESWT, n=30 placebo 
laser, n=20 botox, n=10 polidocanol), n=116 had sham 
surgery (placebo), n=30 had detuned laser (placebo) and 
n=104 had observation only (no treatment). Treatment 
was considered to be combined (surgery +physiotherapy) 
in three studies, wherein it was specifically stated that the 
postoperative physiotherapy was the same as or similar 
to the regime administered to the physiotherapy only 
group.27–29 Patients treated with surgery in all other 
studies followed a standard postoperative rehabilitation 
programme. Affected tendons had one of shoulder tend-
inopathy (n=876), lateral elbow tendinopathy (n=122), 
patellar tendinopathy (n=40) or Achilles tendinopathy 
(n=20). Of the tendons treated surgically (including 
sham surgery), n=177 operations were performed open 
and n=398 arthroscopically. Surgery in those with lateral 
elbow tendinopathy, Achilles and patellar tendinopathy 
was open in all cases while that for shoulder tendinop-
athy was either open (n=45) or arthroscopic (n=398). A 
total of eight studies were controlled as at least one of 
their treatment groups received either placebo (detuned 
laser or sham surgery) or an exercise regime which has 
repeatedly been proven to be effective and is currently 
recommended as first-line treatment for all tendinopa-
thies. Mean age was 48.0 years (range 18–72). All studies 
included patients with chronic tendinopathy (duration 
of symptoms >3 months). Length of follow-up varied 
from 6 months to >10 years (median 12 months). Publi-
cation years ranged from 1993 to 2018.
Table 1 shows the methodological characteristics and 
table 2 presents the summary of samples, interventions 
and outcome measures of the included studies.
Quality assessment
Table 3 illustrates our assessment of internal validity, 
external validity, precision and overall quality of each 
study. Six studies were found to be of ‘poor’ overall 
quality, four of ‘moderate’ quality and two of ‘good’ 
quality.
Internal validity
Selection bias
All 12 studies were randomised. Nine (9) studies were 
thought to have ‘low’ risk of bias and one study was 
labelled as ‘high’ risk as randomisation was based on 
whether reimbursement for ESWT was approved by the 
insurance company.30 The randomisation method was not 
described in sufficient detail in two studies31 32 (‘unclear’ 
risk). Risk of bias with regard to allocation concealment 
was considered ‘low’ in seven studies wherein either 
randomisation was performed by an independent statis-
tician, a centralised telephone randomisation centre or 
the authors specifically state that sealed/closed/opaque 
envelopes were used.22 27 29 31 33–35 The remaining five were 
classified as ‘unclear’ risk as details were not provided.
Performance bias
Patients were only blinded in the two studies that 
compared surgery with sham surgery.22 34 However, in the 
study by Beard et al,34 only the two of the three groups 
were blinded. As some patients received no treatment, 
the part of the study that compared the surgical groups 
to the no treatment group was rated as ‘high’ risk of bias; 
the part that compared the two surgical treatments was 
‘low’ risk. In the remaining 10 studies, blinding of partici-
pants was not possible (surgery vs non-surgical treatment; 
‘high’ risk).
Detection bias
Blinding of outcome measures was thought to be suffi-
cient (‘low’ risk) in studies wherein attempts were made 
to blind the assessors by (a) using independent assessors, 
(b) asking the participants not to disclose the nature of 
their treatment to assessors and to (c) wear t-shirts to 
hide surgical scars were applicable.22 28 29 34 36 37 All other 
studies (n=6) were labelled as ‘high risk’.
Attrition bias
Reasons for dropouts/withdrawals of participants were 
adequately reported in all studies (‘low’ risk) but one37 
(‘high’ risk). Rate of follow-up completion was consid-
ered of ‘high’ risk in the study by Farfaras et al,28 where 
it was only 63%. In the study by Kroslak & Murrell,22 
follow-up completion rate was 85% for the self-rated 
outcomes but only 42% for the clinical tests; however, 
the study was rated as ‘low’ risk of bias as the primary 
outcome measure was self-rated (frequency of elbow pain 
during activity at 6 months).
Reporting bias
Reporting of results was found to be inappropriate or 
inadequate in five studies (‘high’ risk); Alfredson et al,33 
Rahme et al37 and Ketola et al29 only included self-re-
ported parameters in their outcome measures and 
additionally the first two studies only included VAS for 
pain (Rahme et al37) or VAS for pain and satisfaction 
(Alfredson et al33). Keizer et al32 used categorical variables 
in their analysis with an inappropriately small number of 
categories in some cases; for example, ROM was classified 
as either ‘normal’ or ‘limited (>5 degrees)’. Additionally, 
Alfredson et al33 did not include any graphical or tabular 
representation of their results. Brox et al36 and Alfredson 
et al33 did not present details, statistical comparisons or 
p values for some of their findings. The remaining six 
studies were rated as ‘low’ risk.
Other bias
Inclusion and exclusion criteria were thought to be 
adequate for all but two studies: Alfredson et al33 did not 
mention any eligibility criteria at all and the exclusion 
criteria of Rahme et al37 was limited to ‘glenohumeral 
osteoarthritis and those requiring resection of the lateral 
copyright.
 o
n
 10 M
ay 2019 by guest. Protected by
http://bmjopensem.bmj.com/
BM
J O
pen Sport Exerc M
ed: first published as 10.1136/bmjsem-2019-000528 on 24 April 2019. Downloaded from 
5Challoumas D, et al. BMJ Open Sport Exerc Med 2019;5:e000528. doi:10.1136/bmjsem-2019-000528
Open access
Ta
b
le
 1
 
M
et
ho
d
ol
og
ic
al
 c
ha
ra
ct
er
is
tic
s 
of
 in
cl
ud
ed
 s
tu
d
ie
s
Fi
rs
t 
au
th
o
r—
 
te
nd
in
o
p
at
hy
S
tu
d
y 
ty
p
e
R
an
d
o
m
is
at
io
n 
m
et
ho
d
B
lin
d
in
g
 m
et
ho
d
A
llo
ca
ti
o
n 
co
nc
ea
lm
en
t
S
ta
ti
st
ic
al
 p
o
w
er
 
ca
lc
ul
at
io
n
B
as
el
in
e 
co
m
p
ar
is
o
n
In
cl
us
io
n 
cr
it
er
ia
E
xc
lu
si
o
n 
cr
it
er
ia
Fo
llo
w
-u
p
 
co
m
p
le
ti
o
n
B
ro
x3
6 —
S
ho
ul
d
er
R
an
d
om
is
ed
 
co
nt
ro
lle
d
 t
ria
l
R
an
d
om
 p
er
m
ut
ed
 
b
lo
ck
s
P
at
ie
nt
s 
w
ea
rin
g 
t-
sh
irt
s 
at
 fo
llo
w
-
up
 t
o 
hi
d
e 
sc
ar
; 
p
at
ie
nt
s 
as
ke
d
 n
ot
 
to
 t
al
k 
to
 a
ss
es
so
r 
ab
ou
t 
tr
ea
tm
en
t
–
Ye
s,
 9
0%
Le
ss
 w
om
en
 in
 
su
rg
er
y 
gr
ou
p
A
ge
 1
8–
66
 y
, s
ho
ul
d
er
 p
ai
n 
fo
r 
>
3 
m
, r
es
is
ta
nt
 t
o 
p
hy
si
o 
an
d
 
d
ru
gs
, d
ys
fu
nc
tio
n/
p
ai
n 
on
 
ab
d
uc
tio
n,
 n
or
m
al
 p
as
si
ve
 R
O
M
, 
p
ai
n 
d
ur
in
g 
tw
o 
of
 t
he
 t
hr
ee
 
is
om
et
ric
-e
cc
en
tr
ic
 t
es
ts
, p
os
iti
ve
 
im
p
in
ge
m
en
t 
te
st
s
A
cr
om
io
cl
av
ic
ul
ar
 jo
in
t 
ar
th
rit
is
, 
ce
rv
ic
al
 s
yn
d
ro
m
e,
 r
ot
at
or
 c
uf
f 
ru
p
tu
re
, g
le
no
hu
m
er
al
 in
st
ab
ili
ty
, 
b
ila
te
ra
l m
us
cu
la
r 
p
ai
n 
w
ith
 
te
nd
er
ne
ss
 a
nd
 s
ev
er
el
y 
d
ec
re
as
ed
 
ab
ili
ty
 t
o 
re
la
x 
th
e 
sh
ou
ld
er
/
ne
ck
/t
em
p
or
om
an
d
ib
ul
ar
 jo
in
t 
on
 
ex
am
in
at
io
n,
 r
el
uc
ta
nt
 t
o 
ac
ce
p
t 
on
e 
or
 m
or
e 
of
 t
he
 t
re
at
m
en
t 
re
gi
m
en
s 
of
 
th
e 
st
ud
y
99
%
R
ah
m
e3
7
—
S
ho
ul
d
er
R
an
d
om
is
ed
 
co
nt
ro
lle
d
 t
ria
l
B
lo
ck
ed
 
ra
nd
om
is
at
io
n
In
d
ep
en
d
en
t 
as
se
ss
or
–
N
o
N
o 
co
m
p
ar
is
on
Is
ol
at
ed
 s
ho
ul
d
er
 d
is
ea
se
, 
w
or
ki
ng
 a
ge
, s
ho
ul
d
er
 p
ai
n 
>
1 
y 
at
 
re
st
 a
cc
en
tu
at
ed
 b
y 
m
ov
em
en
ts
 
in
vo
lv
in
g 
el
ev
at
io
n,
 p
os
iti
ve
 
H
aw
ki
ns
 (i
m
p
in
ge
m
en
t) 
si
gn
, 
p
os
iti
ve
 im
p
in
ge
m
en
t 
te
st
 (r
el
ie
f 
of
 s
ym
p
to
m
s 
w
ith
in
 1
5 
m
in
 o
f 
in
je
ct
io
n 
of
 lo
ca
l a
na
es
th
et
ic
)
G
le
no
hu
m
er
al
 o
st
eo
ar
th
rit
is
, t
ho
se
 
re
q
ui
rin
g 
re
se
ct
io
n 
of
 t
he
 la
te
ra
l e
nd
 
of
 t
he
 c
la
vi
cl
e
93
%
R
om
p
e3
0 —
S
ho
ul
d
er
R
an
d
om
is
ed
 t
ria
l 
(n
on
-c
on
tr
ol
le
d
)
B
as
ed
 o
n 
w
he
th
er
 
re
im
b
ur
se
m
en
t 
fo
r 
E
S
W
T 
w
as
 a
p
p
ro
ve
d
 
b
y 
in
su
ra
nc
e 
co
m
p
an
y
N
ot
 b
lin
d
ed
–
–
N
o 
d
iff
er
en
ce
s
C
al
ca
re
ou
s 
d
ep
os
it 
on
 s
ta
nd
ar
d
 
A
P
 r
ad
io
gr
ap
hs
 o
f a
 d
ia
m
et
er
 o
f 
at
 le
as
t 
10
 m
m
; t
he
 m
or
p
ho
lo
gi
ca
l 
fe
at
ur
es
 o
f t
he
 d
ep
os
it 
ha
d
 t
o 
b
e 
ho
m
og
en
eo
us
 in
 a
p
p
ea
ra
nc
e 
an
d
 w
ith
 w
el
l-
d
efi
ne
d
 b
or
d
er
s,
 o
r 
in
ho
m
og
en
eo
us
 in
 s
tr
uc
tu
re
 w
ith
 
sh
ar
p
 o
ut
lin
e 
or
 h
om
og
en
eo
us
 in
 
st
ru
ct
ur
e 
w
ith
 n
o 
d
efi
ne
d
 b
or
d
er
, 
sh
ou
ld
er
 p
ai
n 
fo
r 
m
or
e 
th
an
 1
2 
m
, c
lin
ic
al
 s
ig
ns
 o
f s
ub
ac
ro
m
ia
l 
im
p
in
ge
m
en
t,
 u
ns
uc
ce
ss
fu
l 
co
ns
er
va
tiv
e 
th
er
ap
y 
in
 t
he
 
p
re
vi
ou
s 
6 
m
, n
o 
ev
id
en
ce
 o
f 
b
on
e-
re
la
te
d
 a
na
to
m
ic
 o
ut
le
t 
im
p
in
ge
m
en
t 
or
 fu
nc
tio
na
l 
ou
tle
t 
im
p
in
ge
m
en
t 
as
 s
ee
n 
on
 
ra
d
io
gr
ap
hs
 o
r 
M
R
I
C
lo
ud
y 
an
d
 t
ra
ns
p
ar
en
t 
ap
p
ea
ra
nc
e 
of
 d
ep
os
it,
 r
ad
io
lo
gi
ca
l s
ig
ns
 o
f 
sp
on
ta
ne
ou
s 
re
so
rp
tio
n,
 e
vi
d
en
ce
 
of
 t
yp
e 
III
 a
cr
om
ia
l m
or
p
ho
lo
gi
ca
l 
fe
at
ur
e 
ac
co
rd
in
g 
to
 B
ig
lia
ni
 e
t 
al
 
on
 t
he
 o
ut
le
t 
vi
ew
 o
f t
he
 a
cr
om
io
n,
 
ev
id
en
ce
 o
f s
ub
ac
ut
e 
ac
ro
m
ia
l 
b
ur
si
tis
, e
vi
d
en
ce
 o
f a
cr
om
ia
l s
p
ur
 
or
 a
cr
om
io
cl
av
ic
ul
ar
 o
st
eo
p
hy
te
s 
on
 A
P
 r
ad
io
gr
ap
hs
, e
vi
d
en
ce
 o
f 
ro
ta
to
r 
cu
ff 
te
ar
s 
on
 M
R
I, 
ev
id
en
ce
 
of
 fu
nc
tio
na
l i
m
p
in
ge
m
en
t 
of
 r
ot
at
or
 
cu
ff 
on
 U
S
S
 o
r 
ar
th
ro
M
R
I, 
te
ar
s 
of
 t
he
 g
le
no
hu
m
er
al
 li
ga
m
en
ts
 
of
 t
he
 la
b
ru
m
, h
yp
er
tr
op
hy
 o
f 
su
p
ra
sp
in
at
us
 m
us
cl
e,
 d
ys
fu
nc
tio
n 
in
 n
ec
k 
or
 t
ho
ra
ci
c 
re
gi
on
, p
rio
r 
sh
ou
ld
er
 s
ur
ge
ry
, l
oc
al
 d
eg
en
er
at
iv
e 
d
is
ea
se
 o
f s
ho
ul
d
er
, R
A
, n
eu
ro
lo
gi
ca
l 
ab
no
rm
al
iti
es
 o
f t
he
 u
p
p
er
 li
m
b
 w
ith
 
ca
lc
ify
in
g 
te
nd
in
iti
s,
 p
re
gn
an
cy
, 
in
fe
ct
io
n,
 t
um
ou
r
75
%
H
aa
hr
35
—
S
ho
ul
d
er
R
an
d
om
is
ed
 
co
nt
ro
lle
d
 t
ria
l
C
om
p
ut
er
-g
en
er
at
ed
 
ra
nd
om
 s
eq
ue
nc
e 
ge
ne
ra
tio
n
N
ot
 b
lin
d
ed
S
ea
le
d
 
en
ve
lo
p
es
Ye
s,
 8
0%
M
or
e 
si
ck
 le
av
e 
d
ue
 t
o 
m
or
e 
se
ve
re
 s
ho
ul
d
er
 
p
ai
n 
in
 s
ur
ge
ry
 
gr
ou
p
Fu
lfi
lm
en
t 
of
 a
ll 
d
ia
gn
os
tic
 c
rit
er
ia
 
(s
ho
ul
d
er
 p
ai
n,
 p
ai
n 
on
 a
b
d
uc
tio
n 
w
ith
 p
ai
nf
ul
 a
rc
, H
aw
ki
ns
 s
ig
n,
 
p
os
iti
ve
 im
p
in
ge
m
en
t 
te
st
 (r
el
ie
f 
of
 s
ym
p
to
m
s 
w
ith
in
 1
5 
m
in
 o
f 
in
je
ct
io
n 
of
 lo
ca
l a
na
es
th
et
ic
), 
sy
m
p
to
m
s 
6 
m
–-
3 
y,
 a
ge
 1
8–
55
 
y,
 n
or
m
al
 p
as
si
ve
 g
le
no
hu
m
ee
al
 
m
ov
em
en
ts
Im
p
ai
re
d
 g
le
no
hu
m
er
al
 r
ot
at
io
n,
 
hi
st
or
y 
of
 a
cu
te
 t
ra
um
a,
 p
re
vi
ou
s 
su
rg
er
y 
of
 fr
ac
tu
re
 n
ea
r 
af
fe
ct
ed
 
sh
ou
ld
er
, k
no
w
n 
O
A
 in
 g
le
no
hu
m
er
al
 
or
 a
cr
om
io
cl
av
ic
ul
ar
 jo
in
t,
 
cl
ac
ifi
ca
tio
ns
 >
2 
cm
 in
 r
ot
at
or
 c
uf
f 
te
nd
on
s,
 r
up
tu
re
 o
f t
he
 c
uf
f, 
ce
rv
ic
al
 
ro
ot
 s
yn
d
ro
m
es
93
%
C
on
tin
ue
d
copyright.
 o
n
 10 M
ay 2019 by guest. Protected by
http://bmjopensem.bmj.com/
BM
J O
pen Sport Exerc M
ed: first published as 10.1136/bmjsem-2019-000528 on 24 April 2019. Downloaded from 
6 Challoumas D, et al. BMJ Open Sport Exerc Med 2019;5:e000528. doi:10.1136/bmjsem-2019-000528
Open access
Fi
rs
t 
au
th
o
r—
 
te
nd
in
o
p
at
hy
S
tu
d
y 
ty
p
e
R
an
d
o
m
is
at
io
n 
m
et
ho
d
B
lin
d
in
g
 m
et
ho
d
A
llo
ca
ti
o
n 
co
nc
ea
lm
en
t
S
ta
ti
st
ic
al
 p
o
w
er
 
ca
lc
ul
at
io
n
B
as
el
in
e 
co
m
p
ar
is
o
n
In
cl
us
io
n 
cr
it
er
ia
E
xc
lu
si
o
n 
cr
it
er
ia
Fo
llo
w
-u
p
 
co
m
p
le
ti
o
n
K
et
ol
a2
9  
—
S
ho
ul
d
er
R
an
d
om
is
ed
 
co
nt
ro
lle
d
 t
ria
l
C
om
p
ut
er
-g
en
er
at
ed
 
nu
m
b
er
s
In
d
ep
en
d
en
t 
p
hy
si
ot
he
ra
p
is
t 
co
nd
uc
te
d
 5
-y
ea
r 
as
se
ss
m
en
t;
 
p
ar
tic
ip
an
ts
 
w
ea
rin
g 
t-
sh
irt
s 
to
 c
ov
er
 s
ca
rs
 
an
d
 a
sk
ed
 n
ot
 t
o 
in
d
ic
at
e 
tr
ea
tm
en
t 
gr
ou
p
R
an
d
om
is
at
io
n 
b
y 
in
d
ep
en
d
en
t 
st
at
is
tic
ia
n;
se
al
ed
 
en
ve
lo
p
es
Ye
s,
 8
0%
N
o 
d
iff
er
en
ce
 
in
 o
ut
co
m
e 
m
ea
su
re
s,
 n
o 
co
m
p
ar
is
on
 o
f 
d
em
og
ra
p
hi
cs
C
lin
ic
al
 s
ym
p
to
m
s 
of
 s
ho
ul
d
er
 
im
p
in
ge
m
en
t,
 p
os
iti
ve
 N
ee
r’s
 t
es
t,
 
sy
m
p
to
m
s 
fo
r 
at
 le
as
t 
3 
m
, f
ai
le
d
 
m
an
ag
em
en
t 
w
ith
 r
es
t,
 N
S
A
ID
s,
 
st
er
oi
d
 in
je
ct
io
ns
 a
nd
 r
eg
ul
ar
 
p
hy
si
ot
he
ra
p
y,
 a
ge
 1
8–
60
 y
, n
o 
p
re
vi
ou
s 
sh
ou
ld
er
 o
p
er
at
io
ns
, 
w
ill
in
gn
es
s 
an
d
 c
ap
ac
ity
 t
o 
co
m
p
ly
 w
ith
 s
tu
d
y 
p
ro
to
co
l
O
A
, g
le
no
hu
m
er
al
 in
st
ab
ili
ty
, 
p
en
et
ra
tin
g 
ro
ta
to
r 
cu
ff 
ru
p
tu
re
, 
ce
rv
ic
al
 r
ad
ic
ul
op
at
hy
, a
d
he
si
ve
 
ca
p
su
lit
is
, s
ho
ul
d
er
 n
eu
ro
p
at
hy
78
%
Fa
rf
ar
as
28
—
S
ho
ul
d
er
R
an
d
om
is
ed
 
co
nt
ro
lle
d
 t
ria
l
E
nv
el
op
es
 d
iv
id
ed
 in
 
b
ox
es
 b
as
ed
 o
n 
se
x 
an
d
 a
ge
In
d
ep
en
d
en
t 
p
hy
si
ot
he
ra
p
is
t 
co
nd
uc
te
d
 
as
se
ss
m
en
t;
 
p
ar
tic
ip
an
ts
 
en
co
ur
ag
ed
 t
o 
w
ea
r 
a 
t-
sh
irt
 
at
 fo
llo
w
-u
p
 t
o 
co
nc
ea
l t
he
ir 
sc
ar
–
Ye
s,
 s
am
p
le
 
si
ze
 n
ot
 
en
ou
gh
 fo
r 
80
%
 p
ow
er
N
o 
d
iff
er
en
ce
P
os
iti
ve
 N
ee
r 
an
d
 H
aw
ki
ns
 t
es
ts
, 
fa
ile
d
 c
on
se
rv
at
iv
e 
m
an
ag
em
en
t,
 
su
b
ac
ro
m
ia
l p
ai
n 
fo
r 
m
or
e 
th
an
 
6 
m
D
ia
b
et
es
 m
el
lit
us
, n
eu
ro
lo
gi
ca
l o
r 
sp
in
e 
d
is
or
d
er
s,
 r
ad
io
gr
ap
hi
c 
O
A
, 
ch
ro
ni
c 
jo
in
t 
d
is
or
d
er
s,
 fu
ll-
th
ic
kn
es
s 
ro
ta
to
r 
cu
ff 
te
ar
, s
ub
ac
ro
m
ia
l 
im
p
in
ge
m
en
t 
sy
nd
ro
m
e 
st
ag
e 
3
63
%
B
ea
rd
34
—
S
ho
ul
d
er
R
an
d
om
is
ed
 
co
nt
ro
lle
d
 t
ria
l
A
ut
om
at
ed
 
co
m
p
ut
er
-g
en
er
at
ed
 
m
in
im
is
at
io
n 
sy
st
em
D
ou
b
le
 b
lin
d
ed
 
ex
ce
p
t 
‘n
o 
tr
ea
tm
en
t’
 g
ro
up
;
m
as
ke
d
 
as
se
ss
m
en
t
C
en
tr
al
is
ed
 
te
le
p
ho
ne
 
ra
nd
om
is
at
io
n 
ce
nt
re
 u
se
d
Ye
s,
 9
0%
N
o 
d
iff
er
en
ce
S
ub
ac
ro
m
ia
l p
ai
n 
fo
r 
at
 le
as
t 
3 
m
, c
on
su
lta
nt
’s
 c
lin
ic
al
 d
ia
gn
os
is
, 
el
ig
ib
le
 fo
r 
ar
th
ro
sc
op
ic
 s
ur
ge
ry
, 
co
m
p
le
tio
n 
of
 c
on
se
rv
at
iv
e 
m
an
ag
em
en
t 
p
ro
gr
am
m
e 
in
cl
ud
in
g 
p
hy
si
ot
he
ra
p
y 
an
d
 a
t 
le
as
t 
on
e 
st
er
oi
d
 in
je
ct
io
n
Fu
ll-
th
ic
kn
es
s 
ro
ta
to
r 
cu
ff 
te
ar
, 
ot
he
r 
sh
ou
ld
er
 p
at
ho
lo
gy
 id
en
tifi
ed
 
on
 M
R
I o
r 
U
S
S
, p
re
vi
ou
s 
sh
ou
ld
er
 
su
rg
er
y 
on
 a
ffe
ct
ed
 s
id
e,
 R
A
 o
r 
ot
he
r 
in
fla
m
m
at
or
y 
jo
in
t 
co
nd
iti
on
s,
 
ce
rv
ic
al
 s
p
in
e 
p
at
ho
lo
gy
, p
re
vi
ou
s 
se
p
tic
 a
rt
hr
iti
s 
in
 s
ho
ul
d
er
, 
ra
d
io
th
er
ap
y 
in
 s
am
e 
si
d
e 
as
 
af
fe
ct
ed
 s
ho
ul
d
er
, l
ac
ki
ng
 c
on
se
nt
, 
co
gn
iti
ve
 im
p
ai
rm
en
t 
or
 la
ng
ua
ge
 
is
su
es
, u
na
b
le
 t
o 
p
er
fo
rm
 c
lin
ic
al
 
as
se
ss
m
en
ts
, >
75
 y
 o
f a
ge
81
%
B
ah
r2
7 —
P
at
el
la
R
an
d
om
is
ed
 
co
nt
ro
lle
d
 t
ria
l
R
an
d
om
is
at
io
n 
se
q
ue
nc
e 
in
 b
lo
ck
s 
of
 fo
ur
 c
re
at
ed
 
b
y 
st
at
is
tic
ia
n;
 
th
os
e 
w
ho
 h
ad
 
fa
ile
d
 e
cc
en
tr
ic
 
st
re
ng
th
en
in
g 
w
er
e 
al
lo
ca
te
d
 t
o 
se
co
nd
ar
y 
su
rg
er
y 
gr
ou
p
N
ot
 b
lin
d
ed
S
ea
le
d
 
en
ve
lo
p
es
;
ra
nd
om
is
at
io
n 
se
q
ue
nc
e 
cr
ea
te
d
 b
y 
st
at
is
tic
ia
n
Ye
s,
 9
0%
N
o 
d
iff
er
en
ce
s
H
is
to
ry
 o
f e
xe
rc
is
e-
re
la
te
d
 p
ai
n 
in
 p
ro
xi
m
al
 p
at
el
la
r 
te
nd
on
 o
r 
p
at
el
la
r 
in
se
rt
io
n 
an
d
 t
en
d
er
ne
ss
 
to
 p
al
p
at
io
n,
 p
ai
n 
d
ur
in
g 
an
d
 a
ft
er
 
ac
tiv
ity
 a
nd
 u
na
b
le
 t
o 
p
ar
tic
ip
at
e 
in
 s
p
or
ts
 a
t 
sa
m
e 
le
ve
l a
s 
b
ef
or
e 
on
se
t 
of
 p
ai
n,
 t
hi
ck
en
in
g 
an
d
 
in
cr
ea
se
d
 s
ig
na
l i
nt
en
si
ty
 o
n 
M
R
I
H
is
to
ry
 o
f k
ne
e/
p
at
el
la
r 
te
nd
on
 
su
rg
er
y,
 in
fla
m
m
at
or
y 
or
 
d
eg
en
er
at
iv
e 
jo
in
t 
co
nd
iti
on
, 
le
ss
 t
ha
n 
18
 y
 o
f a
ge
, i
na
b
ili
ty
 
to
 u
nd
er
st
an
d
 o
ra
l a
nd
 w
rit
te
n 
N
or
w
eg
ia
n
88
%
A
lfr
ed
so
n3
3 —
A
ch
ill
es
R
an
d
om
is
ed
 t
ria
l 
(n
on
-c
on
tr
ol
le
d
)
B
ox
 w
ith
 e
nv
el
op
es
N
ot
 b
lin
d
ed
O
p
aq
ue
 
en
ve
lo
p
es
N
o
N
o 
co
m
p
ar
is
on
 
as
 in
fo
rm
at
io
n 
no
t 
p
ro
vi
d
ed
–
–
95
%
Ta
b
le
 1
 
C
on
tin
ue
d
C
on
tin
ue
d
copyright.
 o
n
 10 M
ay 2019 by guest. Protected by
http://bmjopensem.bmj.com/
BM
J O
pen Sport Exerc M
ed: first published as 10.1136/bmjsem-2019-000528 on 24 April 2019. Downloaded from 
7Challoumas D, et al. BMJ Open Sport Exerc Med 2019;5:e000528. doi:10.1136/bmjsem-2019-000528
Open access
Fi
rs
t 
au
th
o
r—
 
te
nd
in
o
p
at
hy
S
tu
d
y 
ty
p
e
R
an
d
o
m
is
at
io
n 
m
et
ho
d
B
lin
d
in
g
 m
et
ho
d
A
llo
ca
ti
o
n 
co
nc
ea
lm
en
t
S
ta
ti
st
ic
al
 p
o
w
er
 
ca
lc
ul
at
io
n
B
as
el
in
e 
co
m
p
ar
is
o
n
In
cl
us
io
n 
cr
it
er
ia
E
xc
lu
si
o
n 
cr
it
er
ia
Fo
llo
w
-u
p
 
co
m
p
le
ti
o
n
R
ad
w
an
31
—
La
te
ra
l e
lb
ow
R
an
d
om
is
ed
 t
ria
l 
(n
on
-c
on
tr
ol
le
d
)
C
lo
se
d
 e
nv
el
op
es
N
ot
 b
lin
d
ed
C
lo
se
d
 
en
ve
lo
p
es
Ye
s,
 8
0%
C
ha
ra
ct
er
is
tic
s 
of
 t
w
o 
gr
ou
p
s 
p
re
se
nt
ed
 b
ut
 
co
m
p
ar
is
on
 n
ot
 
p
er
fo
rm
ed
E
st
ab
lis
he
d
 d
ia
gn
os
is
 o
f l
at
er
al
 
ep
ic
on
d
yl
iti
s 
w
ith
 fa
ilu
re
 o
f 
co
ns
er
va
tiv
e 
Tx
 fo
r 
6 
m
 (N
S
A
ID
s,
 
st
er
oi
d
 in
je
ct
io
ns
, p
hy
si
ca
l 
th
er
ap
y,
 e
xe
rc
is
e 
p
ro
gr
am
m
e,
 
el
b
ow
 b
ra
ce
)
P
ai
n 
in
d
uc
ed
 b
y 
>
1 
of
 p
al
p
at
io
n 
of
 
la
te
ra
l e
p
ic
on
d
yl
e,
 r
es
is
te
d
 w
ris
t 
ex
te
ns
io
n,
 c
ha
ir 
te
st
Yo
un
ge
r 
th
an
 1
8 
y,
 lo
ca
l i
nf
ec
tio
n,
 
m
al
ig
na
nc
y,
 e
lb
ow
 a
rt
hr
iti
s,
 
ge
ne
ra
lis
ed
 p
ol
ya
rt
hr
iti
s,
 ip
si
la
te
ra
l 
sh
ou
ld
er
 d
ys
fu
nc
tio
n,
 n
eu
ro
lo
gi
ca
l 
ab
no
rm
al
iti
es
, r
ad
ia
l n
er
ve
 
en
tr
ap
m
en
t,
 c
ar
d
ia
c 
ar
rh
yt
hm
ia
, 
p
ac
em
ak
er
, s
te
ro
id
 in
je
ct
io
n 
la
st
 6
 w
, 
p
re
gn
an
cy
89
%
K
ro
sl
ak
22
—
La
te
ra
l e
lb
ow
R
an
d
om
is
ed
 
co
nt
ro
lle
d
 t
ria
l
C
om
p
ut
er
-g
en
er
at
ed
 
co
d
e
D
ou
b
le
 b
lin
d
ed
S
ea
le
d
, 
un
m
ar
ke
d
 
en
ve
lo
p
es
Ye
s,
 9
0%
 b
ut
 
no
t 
en
ou
gh
 
p
ar
tic
ip
an
t 
re
cr
ui
te
d
 
 
>
18
 y
 o
f a
ge
, c
lin
ic
al
 d
ia
gn
os
is
 
la
te
ra
l e
p
ic
on
d
yl
iti
s 
(p
oi
nt
 
te
nd
er
ne
ss
 o
ve
r 
la
te
ra
l e
p
ic
on
d
yl
e 
an
d
 w
or
se
 p
ai
n 
w
ith
 c
ha
ir 
p
ic
k-
up
 t
es
t 
an
d
 m
ax
im
al
 h
an
d
 g
rip
), 
fa
ile
d
 c
on
se
rv
at
iv
e 
th
er
ap
y 
fo
r 
6 
m
 (i
nc
lu
d
in
g 
in
je
ct
io
ns
)
P
re
vi
ou
s 
su
rg
er
y 
or
 d
is
lo
ca
tio
n 
of
 
af
fe
ct
ed
 e
lb
ow
, s
te
ro
id
 in
je
ct
io
n 
in
 
la
st
 3
 m
, i
na
d
eq
ua
te
 s
ki
n 
co
ve
ra
ge
 
ov
er
 e
lb
ow
, s
en
so
ry
/m
ot
or
 c
ha
ng
es
 
d
is
ta
l t
o 
el
b
ow
, u
nw
ill
in
gn
es
s/
in
ab
ili
ty
 t
o 
at
te
nd
 fo
llo
w
-u
p
 o
r 
en
te
r 
ei
th
er
 t
re
at
m
en
t 
ar
m
85
%
(4
2%
 fo
r 
cl
in
ic
al
 
as
se
ss
m
en
t)
A
P,
 a
nt
er
o-
p
os
te
rio
r;
 E
S
W
T,
 e
xt
ra
co
rp
or
ea
l s
ho
ck
 w
av
e 
th
er
ap
y;
 m
, m
on
th
s;
 M
R
I; 
m
ag
ne
tic
 r
es
on
an
ce
 im
ag
in
g;
 N
S
A
ID
s,
 n
on
-s
te
ro
id
al
 a
nt
i-
in
fla
m
m
at
or
y 
d
ru
gs
; O
A
, o
st
eo
ar
th
rit
is
; R
A
, r
he
um
at
oi
d
 a
rt
hr
iti
s;
 R
O
M
, r
an
ge
 o
f m
ov
em
en
t;
 U
S
S
, 
ul
tr
as
ou
nd
 s
ca
n;
 w
, w
ee
ks
; y
, y
ea
rs
.
Ta
b
le
 1
 
C
on
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d
end of the clavicle’. Baseline characteristics of the treat-
ment control groups were presented by all but two studies 
(‘high’ risk; Alfredson et al33 and Rahme et al37). Of the 
remaining 10 studies, one did not perform statistical 
analyses comparing the two groups at baseline (‘unclear’ 
risk; Radwan et al38), one only compared outcome 
measures and not demographics (‘unclear’ risk; Ketola 
et al29). Eight (8) studies performed adequate baseline 
comparisons; five of them reported no differences in 
demographics or outcome measures between treatment 
groups (‘low’ risk; Bahr et al,27 Beard et al,34 Farfaras et 
al,28 Kroslak & Murrell,22 Rompe et al30) and the other 
three found trivial differences that were regarded as 
introducing ‘low’ risk of bias (Brox et al,36 Haahr et al35 
and Keizer et al32 (table 1). The risk of ‘other’ bias in 
the study by Keizer et al32 was classified as ‘high’ as some 
of the patients in their botox group received a second 
injection at 6 weeks follow-up and some others ended up 
having surgery. Appropriate statistical tests and compari-
sons were deployed in all studies except for Rahme et al37 
who utilised a ‘as treated’ and not a ‘intention-to-treat’ 
basis when comparing groups at 12 months, although 
the authors themselves acknowledge this limitation in 
the manuscript.
external validity
General, non-specific populations were used in all 
studies. Age ranges of participants were wide enough 
to allow for good generalisability in all studies. Clini-
cally relevant assessment tools and outcome measures 
were used in nine studies. Alfredson et al33 and Rahme 
et al37 only included self-reported pain and satisfaction, 
whereas Ketola et al29 used a much greater number of 
measures, all of which were, however, also self-reported 
(‘high’ risk). The nature, frequency and intensity of 
physiotherapy that were considered appropriate were 
used, and no guidelines exist about the best formulation 
or dosage of the other non-surgical treatments (botox, 
polidocanol and ESWT) in clinical practice; therefore, 
all doses and frequencies used were considered clinically 
relevant (‘low’ risk).
Precision
Statistical power calculation prior to recruitment was 
performed in all but three studies (Alfredson et al,33 
Keizer et al32 and Rompe et al30). The studies by Alfredson 
et al33 and Keizer et al32 had small sample sizes (n=20 and 
n=40, respectively) in addition to their failure to perform 
statistical power calculation; therefore, they were rated as 
‘high’ risk of bias. The study by Rompe et al30 was classi-
fied as ‘unclear’ risk as its much larger sample size (n=79) 
is comparable to studies that recruited to a power of at 
least 80%. Where a power calculation was performed, 
sample sizes were adequate for a power of at least 80% 
except for the study by Farfaras et al28 (‘high’ risk). Levels 
of significance were set at p=0.05 in all studies except for 
that of Alfredson et al33 where the level of significance is 
not stated.
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Findings of included studies
Tables 4a and b provide a summary of midterm (up to 
1-year follow-up) and long-term (>1-year follow-up) 
results along with levels of evidence for the overall results 
of each outcome measure.
Surgery versus no treatment/placebo
One good-quality study compared surgery with no treat-
ment for shoulder tendinopathy. In the study by Beard 
et al,34 at 6-month and 12-month follow-up, the two 
surgical groups (corrective surgery and sham surgery) 
had a higher OSS than the no treatment group at statis-
tical significance. A similar pattern was observed in the 
secondary outcomes, all of which had improved at 6 
months in the corrective surgery group compared with 
the no treatment group. The modified Constant-Murley 
and HADS were statistically in favour of the sham surgery 
group compared with no treatment. At 12 months, the 
only significant difference was observed in the modi-
fied Constant-Murley score, which was higher in the two 
surgical groups compared with the no treatment group. 
Equally, patient satisfaction at 6 months was statistically 
higher in the two surgical groups versus the no treatment 
group; only some of the parameters were statistically 
significant at 12 months in favour of the surgical groups.
Surgery versus placebo (other than sham surgery)
One moderate-quality study compared surgery with 
placebo in patients with shoulder tendinopathy. Brox et 
al36 found that the detuned laser (placebo) group had 
a lower mean improvement in the Neer score and all its 
subcomponents compared with the two other treatment 
groups at 6 months and at this point the authors decided 
not to allocate more patients to the placebo group as it 
appeared to be inferior. Treatment success at 2.5-year 
follow-up was also in favour of the surgical group versus 
no treatment at statistical significance.
Surgery versus sham surgery
Two good-quality studies compared surgery with sham 
surgery. Kroslak & Murrell22 reported no statistically 
significant differences between the two groups in 
perceived pain, function and recovery at 6-month and 
>12-month follow-up. Both groups exhibited statistically 
significant improvements in self-rated pain frequency 
and severity, elbow stiffness and difficulty picking up 
objects at 6-month and >12-month follow-up as well as 
epicondyle tenderness, pronation-supination range, grip 
strength and modified ORI-TETS at 6-month follow-up 
compared with baseline. In the study by Beard et al34 at 
6-month and 12-month follow-up, the two surgical groups 
(corrective surgery and sham surgery) had statistically 
higher OSS than the no treatment group.
Surgery versus physiotherapy
A total of six studies compared surgery with physiotherapy 
in shoulder tendinopathy (n=5) and patellar tendinop-
athy (n=1). Three of them were of moderate and three of 
poor overall quality. Brox et al36 were the first to compare 
surgery and any mode of conservative management with 
a randomised study in patients with shoulder tendinop-
athy. Comparing arthroscopic surgery and physiotherapy, 
there was a statistically insignificant difference in the Neer 
score improvement and pain reduction from moderate 
to mild favouring the surgical group. The latter outcome 
measure was found to be statistically significant when 
the comparisons were adjusted for sex (fewer females in 
the surgical group at baseline) in favour of the surgical 
group. At 2.5-year follow-up, success rates (defined as 
Neer score >80) were similar between those who received 
exercises only and those who received surgery.
In a similar study in patients with shoulder tendinop-
athy, Haahr et al35 reported no differences in Constant 
score (primary outcome) and its sub-scores (pain, func-
tion, ROM, force) between their two groups over 1 
year. Differences in the secondary outcomes (pain and 
dysfunction) were also non-significant at 1-year follow-up. 
Six of the patients in the physiotherapy group (14%) 
ended up having an operation within the 12 months; 
comparisons at 12 months were performed as per ‘inten-
tion-to-treat’ which may have resulted in results being 
biassed in favour of the physiotherapy group. The same 
group38 later found no significant differences between 
the two groups in terms of income transfers, obtaining a 
disability pension 4 years after inclusion and self-reported 
outcomes as measured by the PRIM score 4–8 years after 
inclusion.
Rahme et al,37 in their study of shoulder tendinopathy, 
investigated surgical patients receiving postoperative 
physiotherapy, the nature or further details of which 
are not reported; therefore, we do not consider this as 
combined treatment. Even though the emphasis of the 
study was on predictive factors and pain-generating mech-
anisms, at 6-month follow-up there was no difference in 
the two groups with regard to the proportion who had 
achieved at least 50% reduction of the initial total pain 
score. After the 6-month time point, more than half of 
the physiotherapy group were given the opportunity and 
elected to have surgery and results at 12-month follow-up 
are presented on an ‘as treated’ and not on an ‘intention-
to-treat’ basis.
In their study, Ketola et al29 found no differences 
between patients with shoulder tendinopathy receiving 
physiotherapy versus those receiving physiotherapy plus 
surgery in the primary (self-rated pain) or secondary 
(disability, night pain, SDQ score, number of painful 
days, proportion of pain-free patients) outcomes at 2- and 
5-year follow-up. Both groups demonstrated statistically 
significant differences in all outcome measures at 5-year 
follow-up compared with baseline.
In another shoulder tendinopathy study by Farfaras 
et al,28 both surgical groups (open and arthroscopic) 
received the same physiotherapy regime as the phys-
iotherapy only group postoperatively. Compared with 
baseline, none of the three treatment groups demon-
strated significant differences in the overall SF-36 score 
at follow-up (mean 31 months) with no intergroup 
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differences. All three groups improved significantly in 
terms of internal rotation at follow-up versus baseline 
with no significant difference between groups. The 
Constant score improved at statistical significance from 
baseline to follow-up in the two surgical groups but not 
in the physiotherapy group; however, no significant 
intergroup differences were observed. Active elevation 
strength only improved significantly in the open surgery 
group at follow-up compared with baseline but, similarly, 
the three groups were statistically similar at follow-up. 
The same group reported results of the same patients 
at >10-year follow-up which favour surgery over physio-
therapy. The surgical groups demonstrated significantly 
improved active elevation ROM compared with the 
physiotherapy group, internal rotation improved within 
all groups from baseline to follow-up but not between 
groups and muscle strength only improved significantly 
at follow-up within the open surgery group without inter-
group differences.
In the study by Bahr et al27 in patellar tendinopathy, 
VISA score improved significantly in both groups with 
time; however, there was no statistically significant differ-
ences between the groups at any stage of follow-up. 
Similarly, there were improvements in the leg-press 
strength test with time in both groups but no intergroup 
differences. Jump height did not change in either group 
at any stage of follow-up compared with baseline and the 
two groups were statistically similar. Compared with base-
line, pain scores during functional tests improved at 12 
months but not 6 months in both groups and there were 
no differences between groups. Equally, there was no 
difference in overall treatment satisfaction or return to 
sports between groups at 12 months. Finally, with respect 
to the global evaluation score, the eccentric group 
demonstrated improved outcomes at statistical signif-
icance compared with the surgical group at 3 months; 
however, the two groups were statistically similar at 6 and 
12 months.
Surgery versus ESWT
One poor-quality study and one moderate-quality study 
compared the effectiveness of (open) surgery versus 
ESWT in chronic tendinopathy. Rompe et al30 tested the 
two modalities in patients with shoulder tendinopathy 
and reported improved clinical outcome in terms of the 
UCLA score in the surgical group versus the ESWT group 
at 24 months follow-up. Self-rated pain reduction at 
24-month follow-up was similar between the two groups. 
Finally, hospital stay and absence from work were signifi-
cantly shorter in the ESWT group.
In the study by Radwan et al,31 patients with lateral 
elbow tendinopathy treated surgically exhibited no 
significant differences in any of the outcome measures 
compared with those receiving ESWT at any of the 
follow-up stages. Significant improvements with time 
were observed in all outcome measures in both treat-
ment groups.
Surgery versus botox
One poor-quality study compared surgery with botox injec-
tions in chronic lateral elbow tendinopathy.32 In terms of 
overall results and pain, the two treatment groups were 
statistically comparable at all follow-up stages. Compared 
with the botox group, the surgical group exhibited a 
greater extension deficit at 3 and 6 months but the differ-
ence had disappeared at 12 and 24 months. Sick leave 
was significantly shorter in the surgical group versus the 
botox group at 3 months; however, no statistically signifi-
cant longer-term differences were observed.
Surgery versus polidocanol
One poor-quality study allocated patients with Achilles 
tendinopathy to either surgery (colour Doppler-guided) 
or polidocanol injections.33 At 12-week follow-up, 67% 
of the patients in the polidocanol group and 80% 
of those in the surgical group were satisfied with the 
results and returned to their pre-injury recreational/
sport activity (statistical comparison not presented). 
Pain scores reduced at statistical significance in both 
groups compared with baseline and even though no 
between-group statistical comparisons are presented, 
pain improvement at 12 weeks appears to be similar in 
the two groups (VAS scores 76 to 24 in polidocanol group 
and 75 to 21 in surgical group). At 6 months, 100% of 
the surgical group versus 67% of the polidocanol group 
were satisfied with treatment and returned back to their 
pre-injury recreational/sport activities; again, no statis-
tical comparisons are reported.
dIsCussIon
We found no evidence for superiority of surgery to 
exercise-based therapies in patients with tendinopathy. 
To our knowledge, this is the first systematic review 
comparing surgery with no treatment, sham surgery and 
exercise-based therapies modalities in all tendinopathies.
Some studies advocate surgery for tendinopathies after 
3–6 months of conservative management.27 36 Our anal-
ysis demonstrates that outcomes after tendon loading 
exercises both up to 12 months and longer term are as 
good as surgery, at least for shoulder tendinopathy. An 
interesting finding of our review is that surgery appeared 
to be superior to no treatment or placebo but not to sham 
surgery. While the placebo group that received detuned 
laser in the study by Brox et al36 exhibited no improve-
ment in the Neer shoulder score at 6-months follow-up, 
the group of patients that received no treatment in the 
study by Beard et al34 had a higher OSS at both 6 and 12 
months compared with baseline.
This discrepancy may be a result of different outcome 
measures and/or sample sizes in the two studies or 
other methodological differences. Regardless of this 
discrepancy, surgery was significantly more effective than 
detuned laser and no treatment in the two studies but not 
to sham surgery in the latter study. This is in accordance 
with the findings of Kroslak & Murrell22 who found no 
differences in outcomes with the Nirschl procedure versus 
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sham surgery in patients with lateral elbow tendinopathy. 
According to Beard et al,34 the difference between surgery 
and no treatment, taking into account the similar effects 
of arthroscopic decompression and sham arthroscopy, 
may be attributable to surgical placebo effect, unidenti-
fied effects of arthroscopic assessment of the joint and 
bursa, and rest and postoperative physiotherapy associ-
ated with surgery. Based on their findings, the authors 
state that arthroscopy (with or without decompression) 
could be used for the treatment of shoulder tendinop-
athy but at the same time they suggest assessing other 
management strategies apart from surgery.
Sham surgery in randomised controlled surgical trials 
is gaining increasing popularity despite ethical consid-
erations and studies with sham surgery in orthopaedics 
have reported interesting results.23 39 Compared with 
using a non-surgical control group, sham surgery equa-
lises the placebo effect of surgery and can give more 
realistic insights into the effectiveness of the actual 
surgical procedure in question.40 In their recent system-
atic review of sham surgery in orthopaedics, Louw et al41 
included six studies comparing orthopaedic procedures 
with sham surgery, one of which was the study by Kroslak 
& Murrell22 included in the present review. The authors 
concluded that sham surgery appears to be as effective 
as corrective surgery in terms of pain and disability for 
certain conditions; however, the results are not neces-
sarily generalisable to operations not included in the 
review. This is in accordance to our study, which addi-
tionally showed similar outcomes of sham and corrective 
surgery in function and ROM in shoulder tendinopathy 
and lateral elbow tendinopathy. The exact mechanisms 
of surgery (corrective or sham) leading to improvement 
of outcomes in tendinopathy remain uncertain and the 
possibility of this improvement being due to the postop-
erative tendon rehabilitation cannot be ignored.
Despite the rigour of our review with respect to identi-
fying all the available evidence and the quality assessment 
of the included studies, we recognise study limitations. 
First, due to the small number of eligible studies and the 
different comparisons of surgery with each non-surgical 
treatment modality, our conclusions on most outcomes 
had a poor level of evidence. Equally, due to the lack of 
adequate data, different tendinopathies were clustered 
together in some comparisons (surgery vs sham surgery; 
surgery vs ESWT; surgery vs physiotherapy) to increase 
the strength of evidence. Although we acknowledge this 
as a potential drawback of our study, we expect specific 
treatments may potentially yield to similar (if not iden-
tical) effects on tendinopathies at different sites as they 
share the same pathophysiology. However, we did not 
generalise conclusions on comparisons of modalities to 
include types of tendinopathy that did not contribute 
any results for that specific comparison. Additionally, 
the wide range of outcome measures used by authors 
resulted in lack of homogeneity which made the conduc-
tion of a meta-analysis impossible. The different regimes 
and intensities of physiotherapy and postoperative 
rehabilitation used in studies might have affected the 
results and, in patients treated surgically, the possibility 
of improvement due to the postoperative rehabilitation/
physiotherapy cannot be overlooked. Due to the small 
patient numbers in many of the studies, our inability to 
calculate a minimal clinically important difference may 
mask the fact that statistically significant differences 
differ from ultimate meaningful benefit to these patients 
with tendinopathy. Finally, as the duration of symptoms 
of tendinopathy in some studies27 29 36 was only 3 months, 
natural progression of the disease may have improved 
patient outcomes.
ConClusIon
In this systematic review of 12 eligible RCTs in patients with 
various tendinopathies, surgery was not superior to sham 
surgery in patients with tendinopathy in the midterm and 
long term. Further well-designed randomised studies with 
large populations comparing surgery with both tendon 
loading regimes and sham surgery are warranted. In the 
meantime, we advocate that healthcare professionals who 
treat patients with tendinopathies should reserve surgery 
for selected cases and only after a sufficiently long course 
(12 months) of evidence-based loading exercise has 
failed.
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